Thursday, July 30, 2020 10:54:38 PM
Gets rid of the exchange Deficiency (D).
Recent ACHV News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 10:20:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 10:16:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/16/2026 08:47:39 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 04/16/2026 08:11:38 PM
- Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors • GlobeNewswire Inc. • 04/16/2026 12:57:06 PM
- Achieve Life Sciences Announces Up to $354 Million Private Placement • GlobeNewswire Inc. • 04/16/2026 12:53:49 PM
- Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability • GlobeNewswire Inc. • 03/26/2026 12:30:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/24/2026 08:12:47 PM
- Achieve Life Sciences reports fourth-quarter results in line with expectations • IH Market News • 03/24/2026 12:37:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 11:05:07 AM
- Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 03/24/2026 11:00:00 AM
- Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026 • GlobeNewswire Inc. • 03/17/2026 12:30:00 PM
- Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study • GlobeNewswire Inc. • 03/04/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:09:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:08:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:07:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:06:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2026 09:05:03 PM
- Achieve Life Sciences Announced Granting of New Hire Inducement Awards • GlobeNewswire Inc. • 01/30/2026 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/30/2026 05:15:28 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 01/23/2026 09:04:43 PM
- Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer • GlobeNewswire Inc. • 01/12/2026 01:47:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2026 01:10:03 PM
- Achieve Life Sciences to Host Meetings During the J.P. Morgan Healthcare Conference Week • PR Newswire (US) • 12/17/2025 09:11:00 PM
